Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.

作者: Norihiro Sato , Hiroyuki Matsubayashi , Tadayoshi Abe , Noriyoshi Fukushima , Michael Goggins

DOI: 10.1158/1078-0432.CCR-04-2471

关键词:

摘要: Purpose: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is an increasingly identified precursor to infiltrating ductal adenocarcinoma. Although our knowledge clinical and pathologic features IPMNs increasing, molecular mechanisms underlying these neoplasms remain poorly understood. Experimental Designs: To provide further insight into pathobiology IPMNs, global expression profiling was done determine genes that are inactivated/down-regulated in using oligonucleotide microarrays (Affymetrix). Results: In total, 300 unique transcripts (217 known genes) were as highly underexpressed 12 ( P CDKN1C/p57KIP2 . CDKN1C also decreased many pancreatic cancer cell lines restored following treatment with a DNA methylation inhibitor (5-aza-2′-deoxycitidine) or, more potently, histone deacetylase (trichostatin A). Partial promoter CpG island found most, but not all, reduced expression, detectable IPMNs. Furthermore, subset cancers showed complete hypomethylation LIT1 , imprinting control region important for regulation expression. Complete result deletion methylated allele at 11p15.5 rather than loss imprinting. Conclusions: These findings suggest commonly down-regulated through combination hypermethylation, deacetylation, maternal expressing

参考文章(58)
Ralph H. Hruban, Yoshihiko Tokusashi, Edward Gabrielson, Hiroaki Fujii, Shinichi Kasai, Naoyuki Miyokawa, Mitsuhiro Inagaki, Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. American Journal of Pathology. ,vol. 151, pp. 1447- 1454 ,(1997)
Elizabeth J. Perlman, Andrew P. Feinberg, Kimberly J. Reese, Michael R. DeBaun, Jeffrey S. Thompson, Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor. Cancer Research. ,vol. 56, pp. 5723- 5727 ,(1996)
N. Volkan Adsay, Kevin C. Conlon, Sui Y. Zee, Murray F. Brennan, David S. Klimstra, Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. ,vol. 94, pp. 62- 77 ,(2002) , 10.1002/CNCR.10203
Yunping Lin, Weili Ma, Samuel Benchimol, Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nature Genetics. ,vol. 26, pp. 122- 127 ,(2000) , 10.1038/79102
Hyun-Seok Kim, Jae-Yong Lee, Jae-Bong Park, Jong-Yeon Shin, Jinseu Park, Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Research. ,vol. 60, pp. 262- 265 ,(2000)
Takashi Tokino, Tsutomu Urano, Tomohisa Furuhata, Mieko Matsushima, Takashi Miyatsu, Shin Sasaki, Yusuke Nakamura, Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Human Genetics. ,vol. 97, pp. 625- 631 ,(1996) , 10.1007/BF02281873
Kaspar Z'graggen, Jaime A. Rivera, Carolyn C. Compton, Michael Pins, Jens Werner, Carlos Fernández-del Castillo, David W. Rattner, Kent B. Lewandrowski, Anil K. Rustgi, Andrew L. Warshaw, Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Annals of Surgery. ,vol. 226, pp. 491- 500 ,(1997) , 10.1097/00000658-199710000-00010
M H Lee, I Reynisdottir, J Massague, Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Development. ,vol. 9, pp. 639- 649 ,(1995) , 10.1101/GAD.9.6.639
Michael G House, MingZhou Guo, Christine Iacobuzio-Donahue, James G Herman, Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas Carcinogenesis. ,vol. 24, pp. 193- 198 ,(2003) , 10.1093/CARCIN/24.2.193
Ni Liu, Toru Furukawa, Masao Kobari, Ming-Sound Tsao, Comparative Phenotypic Studies of Duct Epithelial Cell Lines Derived from Normal Human Pancreas and Pancreatic Carcinoma The American Journal of Pathology. ,vol. 153, pp. 263- 269 ,(1998) , 10.1016/S0002-9440(10)65567-8